Home > Insider Trading > Filing (0001181431-11-041105)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1135906	Zalicus Inc.	ZLCS	Pharmaceutical Preparations (2834)	043514457

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1350360	Jason Cole	C/O Zalicus Inc. 245 First Street, 3Rd Floor Cambridge MA 02142	Svp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-07-12	70,947	$1.07	82,203	No	4	M	Direct
Common Stock	Disposition	2011-07-12	70,947	$2.70	11,256	No	4	S	Direct
Common Stock	Acquisiton	2011-07-12	54,687	$0.95	65,943	No	4	M	Direct
Common Stock	Disposition	2011-07-12	54,687	$2.70	11,256	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2011-07-12	42,188	$0.00	42,188	$1.07
Common Stock	Stock Option (Right to Buy)	Disposition	2011-07-12	3,348	$0.00	3,348	$1.07
Common Stock	Stock Option (Right to Buy)	Disposition	2011-07-12	1,117	$0.00	1,117	$1.07
Common Stock	Stock Option (Right to Buy)	Disposition	2011-07-12	5,784	$0.00	5,784	$1.07
Common Stock	Stock Option (Right to Buy)	Disposition	2011-07-12	18,510	$0.00	18,510	$1.07
Common Stock	Stock Option (Right to Buy)	Disposition	2011-07-12	54,687	$0.00	54,687	$0.95

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
32,813	2010-12-21	2016-01-23	No	4	M	Direct
5,023	2010-12-21	2017-01-17	No	4	M	Direct
0	2010-12-21	2016-07-12	No	4	M	Direct
1,954	2010-12-21	2017-07-11	No	4	M	Direct
23,799	2010-12-21	2018-07-15	No	4	M	Direct
240,626	2011-01-15	2020-01-15	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b-5-1 trading plan adopted by the reporting person on May 6, 2011.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.56 to $2.81. The reporting person undertakes to provide to Zalicus Inc., any security holder of Zalicus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2 to this Form 4.
The option vested with respect to 32,813 shares on December 21, 2010, 4,688 shares on January 15, 2011 and 4,688 shares quarterly thereafter.
The option vested with respect to 18,416 shares on December 21, 2010, 1,674 shares on January 17, 2011 and 1,674 shares quarterly thereafter.
The option vested with respect to 4,837 shares on December 21, 2010, 372 shares on January 12, 2011 and 372 shares quarterly thereafter.
The option vested with respect to 4,395 shares on December 21, 2010, 488 shares on January 11, 2011 and 488 shares quarterly thereafter.
The option vested with respect to 13,222 shares on December 21, 2010, 2,644 shares on January 15, 2011 and 2,644 shares quarterly thereafter.
The option vested with respect to 87,500 shares on January 15, 2011 and 21,875 shares quarterly thereafter.